Cita APA (7a ed.)

Cingolani, L., Barberio, B., Zingone, F., Ferronato, A., Bertani, L., Costa, F., . . . Savarino, E. V. (2021). Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator. Nature Portfolio.

Cita Chicago Style (17a ed.)

Cingolani, Linda, et al. Adalimumab Biosimilars, ABP501 and SB5, Are Equally Effective and Safe as Adalimumab Originator. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Cingolani, Linda, et al. Adalimumab Biosimilars, ABP501 and SB5, Are Equally Effective and Safe as Adalimumab Originator. Nature Portfolio, 2021.